PSG — PharmaSGP Holding SE Share Price
Last trade - 00:00- €359.71m
- €396.70m
- €101.10m
- 94
- 39
- 67
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.81 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 15.53 | ||
| Price to Sales | 3.35 | ||
| EV to EBITDA | 11.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 27.39% | ||
| Return on Equity | 44.54% | ||
| Operating Margin | 24.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 62.57 | 63.25 | 65.34 | 85.82 | 101.1 | n/a | n/a | 10.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +12.67 | -29.44 | +0.28 | +11.59 | +25.03 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
Directors
- Clemens Fischer CSU (46)
- Natalie Weigand CEO (40)
- Madlena Hohlefelder VSU (40)
- Michael Rudolf CFO (47)
- Axel Rebien SUB (50)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2025
- Incorporated
- March 20th, 2020
- Public Since
- June 19th, 2020
- No. of Employees
- 93
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Hamburg Stock Exchange
- Shares in Issue
- 11,990,213
- Address
- Lochhamer Schlag 21, GRAEFELFING, 82166
- Web
- https://pharmasgp.com/
- Phone
- +49 898589639150
- Contact
- Claudius Krause
- Auditors
- PricewaterhouseCoopers GmbH
Similar to PSG
FAQ
As of Today at 22:38 UTC, shares in PharmaSGP Holding SE are trading at €30.00. This share price information is delayed by 15 minutes.
Shares in PharmaSGP Holding SE last closed at €30.00 and the price had moved by over the past 365 days. In terms of relative price strength the PharmaSGP Holding SE share price has matched the FTSE Global All Cap Index by over the past year.
The overall consensus recommendation for PharmaSGP Holding SE is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe PharmaSGP Holding SE dividend yield is 4.53% based on the trailing twelve month period.
Last year, PharmaSGP Holding SE paid a total dividend of €1.36, and it currently has a trailing dividend yield of 4.53%. We do not have any data on when PharmaSGP Holding SE is to next pay dividends.
We do not have data on when PharmaSGP Holding SE is to next pay dividends. The historic dividend yield on PharmaSGP Holding SE shares is currently 4.53%.
To buy shares in PharmaSGP Holding SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €30.00, shares in PharmaSGP Holding SE had a market capitalisation of €359.71m.
Here are the trading details for PharmaSGP Holding SE:
- Country of listing: Germany
- Exchange: HAM
- Ticker Symbol: PSG
Based on an overall assessment of its quality, value and momentum PharmaSGP Holding SE is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in PharmaSGP Holding SE is €38.00. That is 26.67% above the last closing price of €30.00.
Analysts covering PharmaSGP Holding SE currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PharmaSGP Holding SE. Over the past six months, its share price has matched the FTSE Global All Cap Index by .
As of the last closing price of €30.00, shares in PharmaSGP Holding SE were trading +4.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The PharmaSGP Holding SE PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €30.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
PharmaSGP Holding SE's management team is headed by:
- Clemens Fischer - CSU
- Natalie Weigand - CEO
- Madlena Hohlefelder - VSU
- Michael Rudolf - CFO
- Axel Rebien - SUB